Investors Buy Large Volume of Cibus Call Options (NASDAQ:CBUS)

Cibus, Inc. (NASDAQ:CBUS) saw some unusual options trading activity on Tuesday. Stock traders purchased 6,983 call options on the company. This represents an increase of approximately 7,409% compared to the typical daily volume of 93 call options.

Analyst Ratings Changes

CBUS has been the topic of several research reports. Canaccord Genuity Group reiterated a “buy” rating and set a $15.00 price objective on shares of Cibus in a report on Monday, December 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cibus in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $20.00.

Cibus Stock Performance

Shares of NASDAQ CBUS opened at $3.26 on Wednesday. The stock has a market cap of $176.95 million, a price-to-earnings ratio of -1.00 and a beta of 1.80. Cibus has a fifty-two week low of $1.09 and a fifty-two week high of $3.40. The firm’s 50-day simple moving average is $1.90 and its 200 day simple moving average is $1.58.

Institutional Investors Weigh In On Cibus

Several institutional investors have recently bought and sold shares of the stock. Gratia Capital LLC bought a new position in Cibus during the 2nd quarter valued at $1,183,000. Geode Capital Management LLC raised its holdings in shares of Cibus by 4.7% in the fourth quarter. Geode Capital Management LLC now owns 275,180 shares of the company’s stock valued at $479,000 after purchasing an additional 12,467 shares during the last quarter. Certior Financial Group LLC lifted its position in shares of Cibus by 46.7% during the fourth quarter. Certior Financial Group LLC now owns 271,164 shares of the company’s stock valued at $472,000 after purchasing an additional 86,378 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new position in Cibus during the fourth quarter worth about $345,000. Finally, Jane Street Group LLC purchased a new position in Cibus during the second quarter worth about $207,000. Institutional investors own 33.81% of the company’s stock.

About Cibus

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.